SK287819B6 - Dry powder pharmaceutical composition for oral administration - Google Patents

Dry powder pharmaceutical composition for oral administration Download PDF

Info

Publication number
SK287819B6
SK287819B6 SK76-2003A SK762003A SK287819B6 SK 287819 B6 SK287819 B6 SK 287819B6 SK 762003 A SK762003 A SK 762003A SK 287819 B6 SK287819 B6 SK 287819B6
Authority
SK
Slovakia
Prior art keywords
pharmaceutical composition
dry powder
racecadotril
powder pharmaceutical
composition according
Prior art date
Application number
SK76-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK762003A3 (en
Inventor
Jeanne-Marie Lecomte
Jean-Charles Schwartz
Original Assignee
Bioprojet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioprojet filed Critical Bioprojet
Publication of SK762003A3 publication Critical patent/SK762003A3/sk
Publication of SK287819B6 publication Critical patent/SK287819B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK76-2003A 2000-06-23 2001-06-22 Dry powder pharmaceutical composition for oral administration SK287819B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00401799 2000-06-23
PCT/EP2001/007086 WO2001097801A2 (fr) 2000-06-23 2001-06-22 Formulation

Publications (2)

Publication Number Publication Date
SK762003A3 SK762003A3 (en) 2003-07-01
SK287819B6 true SK287819B6 (sk) 2011-11-04

Family

ID=8173739

Family Applications (1)

Application Number Title Priority Date Filing Date
SK76-2003A SK287819B6 (sk) 2000-06-23 2001-06-22 Dry powder pharmaceutical composition for oral administration

Country Status (13)

Country Link
US (1) US6919093B2 (fr)
EP (1) EP1294372B1 (fr)
CN (2) CN102151247A (fr)
AT (1) ATE301999T1 (fr)
AU (1) AU2001289606A1 (fr)
BG (1) BG66212B1 (fr)
CA (1) CA2415957C (fr)
CZ (1) CZ299591B6 (fr)
DE (1) DE60112756T2 (fr)
DK (1) DK1294372T3 (fr)
ES (1) ES2247163T3 (fr)
SK (1) SK287819B6 (fr)
WO (1) WO2001097801A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2900823B1 (fr) * 2006-05-15 2009-02-13 Bioprojet Soc Civ Ile Nouvelle forme d'administration du racecadotril.
CN101103960B (zh) * 2006-07-14 2010-12-08 海南盛科生命科学研究院 一种含有消旋卡多曲的干混悬剂及其制备方法
EP2462922A1 (fr) 2010-12-10 2012-06-13 Bioprojet Nouvelle forme d'administration pour inhibiteurs de l'enképhalinase
CN102166197B (zh) * 2011-04-25 2012-09-05 四川百利药业有限责任公司 消旋卡多曲颗粒及其生产工艺
WO2013057570A2 (fr) * 2011-10-18 2013-04-25 Purdue Pharma L.P. Formulations de polymère acrylique
US9114171B2 (en) 2012-06-28 2015-08-25 Mcneil-Ppc, Inc. Racecadotril liquid compositions
PT2866802T (pt) * 2012-06-28 2016-09-05 Johnson & Johnson Consumer Inc Composições líquidas racecadotril
RU2632441C2 (ru) 2012-06-28 2017-10-04 МакНЕЙЛ-ППС, ИНК. Липидные композиции рацекадотрила
US9801819B2 (en) 2012-06-28 2017-10-31 Johnson & Johnson Consumer Inc. Racecadotril compositions
TR201801726T4 (tr) * 2012-12-26 2018-03-21 Ilko Ilac Sanayi Veticaret A S Rasekadotri̇l ve farmasöti̇k bi̇leşi̇mleri̇.
ES2549127T1 (es) 2014-03-10 2015-10-23 Galenicum Health S.L. Composiciones farmacéuticas que comprenden un principio activo
ES2555484T1 (es) * 2014-05-26 2016-01-04 Galenicum Health S.L. Composiciones farmacéuticas que contienen un agente activo
MA40859A (fr) 2014-10-29 2017-09-05 Johnson & Johnson Consumer Inc Particules de cadotril
EP3558272A1 (fr) 2016-12-23 2019-10-30 Hermes Arzneimittel GmbH Composition pharmaceutique orale présentant des propriétés de masquage du goût améliorées
BR112018069973A2 (pt) 2017-03-06 2019-09-17 Athena Drug Delivery Solutions Pvt Ltd uma composição farmacêutica compreendendo racecadotrila e processo para a preparação da mesma
CN109589310A (zh) * 2017-10-01 2019-04-09 北京万全德众医药生物技术有限公司 消旋卡多曲干混悬剂及其制备方法
GB2586201B (en) * 2019-05-14 2023-05-24 Orbit Pharmaceuticals A stable powder formulation of racecadotril
EP4056171A1 (fr) 2021-03-12 2022-09-14 Athena Pharmaceutiques SAS Composition de comprimé de racécadotril au goût masqué et procédé de préparation associé

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480747A1 (fr) * 1980-04-17 1981-10-23 Roques Bernard Derives d'acides amines et leur application therapeutique
ZA919510B (en) * 1990-12-05 1992-10-28 Smithkline Beecham Corp Pharmaceutical compositions
GR1002332B (el) * 1992-05-21 1996-05-16 Mcneil-Ppc Inc. Νεες φαρμακευτικες συνθεσεις που περιεχουν σιμεθεικονη.
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US20020028248A1 (en) * 1996-03-14 2002-03-07 Takayuki Tsukada Rapid-release microdispersible ecadotril preparation
US6649186B1 (en) * 1996-09-20 2003-11-18 Ethypharm Effervescent granules and methods for their preparation
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
GB0015490D0 (en) * 2000-06-23 2000-08-16 Smithkline Beecham Lab Novel formulations

Also Published As

Publication number Publication date
EP1294372A2 (fr) 2003-03-26
ATE301999T1 (de) 2005-09-15
SK762003A3 (en) 2003-07-01
DE60112756T2 (de) 2006-06-08
CZ2003185A3 (cs) 2003-05-14
CA2415957A1 (fr) 2001-12-27
WO2001097801A2 (fr) 2001-12-27
CA2415957C (fr) 2010-08-10
DE60112756D1 (de) 2005-09-22
ES2247163T3 (es) 2006-03-01
CZ299591B6 (cs) 2008-09-10
AU2001289606A1 (en) 2002-01-02
US20030166718A1 (en) 2003-09-04
CN102151247A (zh) 2011-08-17
BG66212B1 (bg) 2012-05-31
WO2001097801A3 (fr) 2002-09-12
BG107481A (bg) 2003-09-30
US6919093B2 (en) 2005-07-19
DK1294372T3 (da) 2005-09-19
CN1635884A (zh) 2005-07-06
EP1294372B1 (fr) 2005-08-17

Similar Documents

Publication Publication Date Title
SK287819B6 (sk) Dry powder pharmaceutical composition for oral administration
KR100780156B1 (ko) 맛 차폐용 코팅 조성물
US5019563A (en) Pharmaceutical composition
US4321253A (en) Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
US4507276A (en) Analgesic capsule
US9034382B2 (en) Oseltamivir phosphate granule and preparation method thereof
AU630536B2 (en) Pimobendan compositions
US8927604B2 (en) Diclofenac formulations and methods of use
IE53543B1 (en) New oral dipyridamole preparations
EA023305B1 (ru) Гранулят гамма-гидроксимасляной кислоты
KR19980702370A (ko) 염기성 물질로 안정화된 약제학적 조성물
HU206265B (en) Process for producing pharmaceutical compositions comprising morphine
SK322002A3 (en) Taste masked pharmaceutical liquid formulations
JPH0259515A (ja) 鎮痛活性及び抗炎症活性を有し、優れた嗜好性をもち、且つ粘膜に刺激作用のない経口投与用製薬組成物
SK146297A3 (en) Composition comprising amoxycillin and clavulanic acid
CA2684586A1 (fr) Composition a dose elevee d'acide ursodesoxycholique
WO2001097803A1 (fr) Preparations pharmaceutiques comportant du racecadotril (acetorphane)
BG60901B1 (bg) Гранулат,съдържащ натриев 2-меркаптоетансулфонаткато активно вещество и метод за получаването му
JPH0296526A (ja) 粉粒状医薬製剤
KR100395864B1 (ko) 트리메부틴을함유하는신규제약조성물및그제조방법
Kulkarni Formulation and Evaluation of Telmisartan Fast Dissolving Tablets by Different Techniques
WO2016038623A2 (fr) Forme posologique pharmaceutique stable au goût masqué
JPS5967222A (ja) 持続性セフアトリジン製剤

Legal Events

Date Code Title Description
MK4A Expiry of patent

Expiry date: 20210622